Accéder au contenu principal

Benzodiazepines and Alzheimer

Use of benzodiazepines to treat insomnia or anxiety may increase the risk for Alzheimer's disease (AD), new research suggests.
Dr. Sophie Billioti de Gage
A case-control study of nearly 9000 older individuals showed that risk for AD was increased by 43% to 51% in those who had "ever used" benzodiazepines in the previous 5 years.
The association was even stronger in participants who had been prescribed benzodiazepines for 6 months or longer ― and in those who used long-acting versions of the medications.
Lead author Sophie Billioti de Gage, PharmD, who is also a PhD student and researcher at INSERM Unit 657–Pharmacoepidemiology at the University of Bordeaux, France, toldMedscape Medical News that the overall results were not a surprise because the short-term deleterious effects of these medications on memory are well documented. A study published by the same researchers last year showed a 50% increased risk for dementia in patients using benzodiazepines.
"The nature of the link (causal or not) is still not definitive, but these conclusions reinforce the suspicion of a possible direct association," said Dr. Billioti de Gage.
The investigators note that although these medications are important treatment options, clinicians should "comply with good practice guidelines" and prescribe benzodiazepines for as short a time as possible. In addition, use should not exceed 3 months.
"For people needing or using benzodiazepines, it seems crucial to encourage physicians to carefully balance the benefits and risks when initiating or renewing a treatment," added Dr. Billioti de Gage.
The study was published online September 9 in BMJ.
Public Health Implications
The researchers examined data from the Quebec, Canada, health insurance program database for 1796 individuals with a first diagnosis of AD who were older than 66 years (67% women) and who had exposure to benzodiazepines at least 5 years prior.
These patients were compared with 7184 sex- and age-matched healthy individuals; 6-year follow-up data were assessed for all participants.
Cumulative use of the medications was grouped into 3 subcategories of prescribed daily doses: 1 to 90, 91 to 180, and more than 180.

>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>> SOURCE

Commentaires

Posts les plus consultés de ce blog

The Muse Brooklyn

http://abcirque.com http://www.amny.com/things-to-do/circus-class-at-the-muse-brooklyn-teaches-acrobatic-skills-1.13781898 https://www.instagram.com/p/Bx-D67pAxGz/ https://www.instagram.com/p/Bx7e3GFgpp2/ https://www.instagram.com/p/Bx5xpoPn_hm/ https://www.instagram.com/p/Bx40FSvj2Tf/ https://www.instagram.com/p/Bx0p224DkxE/ https://www.instagram.com/p/BxzxjhqFO1S/ https://www.instagram.com/p/BxyJmIaAeSd/ https://www.instagram.com/p/BxxweSaF6q4/ https://www.instagram.com/p/BxxSsdcAjFg/ https://www.instagram.com/p/Bxvr0SSgpPs/ https://new.mta.info/L-Project http://themusegowanus.com http://instagram.com/themusebrooklyn https://www.facebook.com/TheMuseBrooklyn/ https://twitter.com/TheMuseBrooklyn https://www.youtube.com/channel/UCkzh62AIfOI7XU3I0P6rWIQ

Fw:

Consider this message as your last warning. We hacked your system! We have copied all the data from your device to our own servers. Curious videos were recorded from your camera and your actions while watching porn. Your device was infected with our virus when you visited the porn site. The Trojan virus gives us full access, allows us to control your device. The virus allows not only to see your screen, but also to turn on your camera, microphone, without your knowledge. We took over the video from your screen and camera, then we mounted a video in which you can see you watching porn in one part of the screen and masturbating in the other. But that’s not all! We have access to all the contacts in your phone book and social networks. It won’t take us long to send this video to your friends, family and friends on social networks, messengers and email in minutes. We have a lot of audio recordings of your personal conversations, where a lot of “intere...

Systemic Lidocaine Decreased the Perioperative Opioid Analgesic Requirements but Failed to Reduce Discharge Time After Ambulatory Surgery

Perioperative systemic lidocaine significantly reduces opioid requirements in the ambulatory setting without affecting time to discharge. Postoperative pain is the most common reason for delay in discharge and unplanned hospital admission after ambulatory surgery. 1–3 Because postoperative pain is to a large extent an inflammatory phenomenon, administration of systemic local anesthetics, which have inflammatory modulatory properties, 4 could significantly reduce pain and therefore allow more rapid discharge. 5 Lidocaine has an excellent safety record when administered by low-dose infusion. 5–7 However, whereas decreased hospital stay after inpatient surgery has been demonstrated, the effect of intraoperative and early postoperative lidocaine infusion on duration of stay after ambulatory surgery is not known. Although it see...